Ibandronate Sodium Patent Expiration
Ibandronate Sodium is Used for the treatment and prevention of osteoporosis in postmenopausal women. It was first introduced by Hoffmann La Roche Inc
Ibandronate Sodium Patents
Given below is the list of patents protecting Ibandronate Sodium, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Boniva | US7192938 | Method of treatment using bisphosphonic acid |
May 06, 2023
(Expired) | Hoffmann La Roche |
| Boniva | US7410957 | Method of treatment using bisphosphonic acid |
May 06, 2023
(Expired) | Hoffmann La Roche |
| Boniva | US7718634 | Method of treatment using bisphosphonic acid |
May 06, 2023
(Expired) | Hoffmann La Roche |
| Boniva | US6294196 | Pharmaceutical composition containing diphosphonic acid or salt thereof |
Oct 07, 2019
(Expired) | Hoffmann La Roche |
| Boniva | US6143326 | Oral pharmaceutical preparation containing ibandronat |
Apr 21, 2017
(Expired) | Hoffmann La Roche |
| Boniva | US5662918 | Pharmaceutical agents containing diphosphonic acids and salts thereof |
Sep 02, 2014
(Expired) | Roche |
Ibandronate Sodium's Family Patents
Explore Our Curated Drug Screens
Ibandronate Sodium Generic API Manufacturers
Several generic applications have been filed for Ibandronate Sodium. The first generic version for Ibandronate Sodium was by Norvium Bioscience Llc and was approved on Mar 19, 2012. And the latest generic version is by Nang Kuang Pharmaceutical Co Ltd and was approved on Jun 16, 2021.
Given below is the list of companies who have filed for Ibandronate Sodium generic, along with the locations of their manufacturing plants worldwide.
1. ACCORD HLTHCARE
Accord Healthcare Inc has filed for 1 generic for Ibandronate Sodium. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 3MG BASE/3ML | injectable | Prescription | INTRAVENOUS | AP | Feb 5, 2016 |
2. APOTEX
Apotex Inc has filed for 1 generic for Ibandronate Sodium. Given below are the details of the strengths of this generic introduced by Apotex.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 3MG BASE/3ML
(reference standard) | injectable | Prescription | INTRAVENOUS | AP | Oct 16, 2015 |
Manufacturing Plant Locations New
Apotex's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Apotex as present at those locations.
| Country | City | Firm Name | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||
| Canada |
| |||||||||||||
| India |
| |||||||||||||
3. APOTEX INC
Apotex Inc has filed for 1 generic for Ibandronate Sodium. Given below are the details of the strengths of this generic introduced by Apotex Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 150MG BASE | tablet | Prescription | ORAL | AB | Mar 19, 2012 |
Manufacturing Plant Locations New
Apotex Inc's manufacturing plants are situated in 1 country - Canada. Given below are the details of these plant locations as well as the firm names of Apotex Inc as present at those locations.
| Country | City | Firm Name | ||||||
|---|---|---|---|---|---|---|---|---|
| Canada |
| |||||||
4. AUROBINDO PHARMA
Aurobindo Pharma Ltd has filed for 1 generic for Ibandronate Sodium. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 150MG BASE | tablet | Prescription | ORAL | AB | Mar 11, 2016 |
Manufacturing Plant Locations New
Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||
| United States |
| |||||||||
5. AVET LIFESCIENCES
Avet Lifesciences Ltd has filed for 1 generic for Ibandronate Sodium. Given below are the details of the strengths of this generic introduced by Avet Lifesciences.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 3MG BASE/3ML | injectable | Discontinued | INTRAVENOUS | N/A | Sep 2, 2014 |
6. CHEMI SPA
Chemi Spa has filed for 1 generic for Ibandronate Sodium. Given below are the details of the strengths of this generic introduced by Chemi Spa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 3MG BASE/3ML | injectable | Prescription | INTRAVENOUS | AP | Sep 2, 2014 |
7. DR REDDYS LABS LTD
Dr Reddys Laboratories Ltd has filed for 1 generic for Ibandronate Sodium. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 150MG BASE
(reference standard) | tablet | Prescription | ORAL | AB | Apr 30, 2012 |
8. EUGIA PHARMA
Eugia Pharma Specialities Ltd has filed for 1 generic for Ibandronate Sodium. Given below are the details of the strengths of this generic introduced by Eugia Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 3MG BASE/3ML | injectable | Prescription | INTRAVENOUS | AP | Aug 19, 2015 |
Manufacturing Plant Locations New
Eugia Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Eugia Pharma as present at those locations.
| Country | City | Firm Name | ||||||
|---|---|---|---|---|---|---|---|---|
| India |
| |||||||
9. MACLEODS PHARMS LTD
Macleods Pharmaceuticals Ltd has filed for 1 generic for Ibandronate Sodium. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 150MG BASE | tablet | Prescription | ORAL | AB | Oct 31, 2017 |
10. MYLAN LABS LTD
Mylan Laboratories Ltd has filed for 1 generic for Ibandronate Sodium. Given below are the details of the strengths of this generic introduced by Mylan Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 3MG BASE/3ML | injectable | Prescription | INTRAVENOUS | AP | Sep 2, 2014 |
11. NANG KUANG PHARM CO
Nang Kuang Pharmaceutical Co Ltd has filed for 1 generic for Ibandronate Sodium. Given below are the details of the strengths of this generic introduced by Nang Kuang Pharm Co.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 3MG BASE/3ML | injectable | Discontinued | INTRAVENOUS | N/A | Jun 16, 2021 |
12. NORVIUM BIOSCIENCE
Norvium Bioscience Llc has filed for 1 generic for Ibandronate Sodium. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 150MG BASE | tablet | Discontinued | ORAL | N/A | Mar 19, 2012 |
13. ORBION PHARMS
Orbion Pharmaceuticals Private Ltd has filed for 1 generic for Ibandronate Sodium. Given below are the details of the strengths of this generic introduced by Orbion Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 150MG BASE | tablet | Prescription | ORAL | AB | Mar 19, 2012 |
14. SUN PHARM
Sun Pharmaceutical Industries Ltd has filed for 1 generic for Ibandronate Sodium. Given below are the details of the strengths of this generic introduced by Sun Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 3MG BASE/3ML | injectable | Discontinued | INTRAVENOUS | N/A | Feb 14, 2014 |
Manufacturing Plant Locations New
Sun Pharm's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Sun Pharm as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||||||||||||||
| India |
| |||||||||||||||||||||||||||||
15. SUN PHARM INDUSTRIES
Sun Pharmaceutical Industries Inc has filed for 1 generic for Ibandronate Sodium. Given below are the details of the strengths of this generic introduced by Sun Pharm Industries.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 150MG BASE | tablet | Discontinued | ORAL | N/A | Aug 15, 2012 |
16. WATSON LABS TEVA
Watson Laboratories Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc has filed for 1 generic for Ibandronate Sodium. Given below are the details of the strengths of this generic introduced by Watson Labs Teva.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 150MG BASE | tablet | Discontinued | ORAL | N/A | Mar 20, 2012 |